SIRT1 and Alzheimer disease: Patients with AD and mild cognitive impairment have been found to exhibit lower levels of SIRT1 compared to healthy individuals [109], indicating that measuring serum SIRT1 levels could potentially serve as an early biomarker for AD diagnosis.